Search

everythinglearnresearchcommunity

for

Search:↓

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

Timolol eye-drops can cause hair loss.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Minoxidil treats high blood pressure and side effects can be managed.

Scientists developed a cheaper, but slower, method to measure minoxidil in hair loss treatments with high accuracy.

Low-dose oral minoxidil improved hair growth in a woman with short anagen syndrome.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

The new delivery system could improve pain and inflammation relief in gout.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Platelet-rich plasma is a safe and effective treatment for oral lichen planus.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Cetosomal minoxidil alone and with finasteride is effective and well-tolerated for hair loss treatment.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Long-term treatment with buprenorphine/naloxone for opioid addiction may lead to secondary adrenal insufficiency.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Cosmetics with hinokitiol-loaded nanocapsules were found to effectively promote hair growth.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.